Gerstner Center for Cancer Diagnostics

While many aspects of cancer treatment have improved substantially over the past decade, diagnostics have lagged. Most current diagnostic approaches are costly, invasive, and most importantly, provide no molecular insights.

Blood biopsies have the potential to monitor a patient’s response to treatment with molecular precision, with the potential to identify tumor recurrence much earlier than existing tests. As a result, blood biopsy can help patients and doctors determine whether a change in treatment is needed.